Giant cell arteritis (GCA) is characterized by intimal hyperplasia and luminal obstruction leading
to ischemic manifestations involving extra-cranial branches of carotid arteries and aorta. …

Giant cell arteritis is a primary large-vessel vasculitis characterized by an arterial wall
inflammation associated with intimal hyperplasia leading to arterial occlusion. Glucocorticoids …

CD8 + T cells participate in the pathogenesis of some vasculitides. However, little is known
about their role in Giant Cell Arteritis (GCA). This study was conducted to investigate CD8 + T …

Purpose The purpose of our study was to assess the concordance of aortic CT angiography
(CTA) and FDG-PET/CT in the detection of large-vessel involvement at diagnosis in patients …

Objective. To determine the risk factors for permanent visual loss (PVL) in patients with
biopsy-proven giant cell arteritis (GCA) and the usefulness of the factors in clinical practice. …

OBJECTIVES: Hereditary haemorrhagic telangiectasia (HHT) is a rare autosomal dominant
disorder that can lead to neurological manifestations including strokes and cerebral …

Objective. To report the efficacy and safety of tocilizumab (TCZ) for giant cell arteritis (GCA).
Methods. A retrospective multicenter study that included 34 patients receiving TCZ for GCA. …

Objective. To estimate the frequency of different clinical patterns in giant-cell arteritis (GCA)
at onset. Methods. All GCA patients consecutively followed-up in two referral centers for GCA …

Large-vessel involvement (LVI) in giant cell arteritis (GCA) includes different clinical and
imaging patterns that are rarely described separately at diagnosis and whose specific …

Objectives Giant cell arteritis (GCA) is a chronic systemic vasculitis of large and medium-sized
arteries, for which long-term glucocorticoid (GC) treatment is needed. During GC …